In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read standard print, after five years of treatment with anti-VEGF drugs that are injected into the eye.
David Watson has worn glasses to correct nearsightedness the majority of his life, and had his vision checked regularly to make sure his prescription was up to date. But when his wife convinced him to have a comprehensive dilated eye exam, he got a surprise.
Robert Nussenblatt, M.D., chief of the Laboratory of Immunology at the National Eye Institute (NEI), died on April 17 at age 67.
News from NEI Grantees
- Researchers Find Immunosuppressive Medication An Effective Treatment For Ocular Graft-Versus-Host-Disease April 13, 2016
- Scientists reveal new target for anti-lymphangiogenesis drugs April 12, 2016
- Largest Eye Study Among Chinese Americans Identifies More Effective Ways to Prevent and Treat Blinding Eye Diseases for This Racial Group April 8, 2016
- Neuronal Feedback Could Change What We “See” March 29, 2016
- Nerve injury appears to be root of diabetes-related vision loss March 23, 2016
- IUPUI researchers use stem cells to identify cellular processes related to glaucoma March 21, 2016
- Before retinal cells die, they regenerate, Penn Vet blindness study finds March 18, 2016